Information about the Serious Scarcity Substitution Instrument (SSSI) for tocilizumab to assist with timely access for patients using subcutaneous formulations.
The TGA has granted provisional approval to Moderna Australia Pty Ltd in relation to the COVID-19 vaccine, Spikevax (elasomeran), for individuals aged 12 years and over.